Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01425060 · ClinicalTrials.gov registry record · Phase 1
Improving Effective Contraceptive Use Among Opioid-maintained Women
A Phase 1 study, sponsored by University of Vermont.
- Completed
- Registry status
- Phase 1
- Development phase
- 31
- Enrollment target
NCT01425060 is a Phase 1 study that has completed, run by University of Vermont. The registered enrollment target is 31 participants.
The verdict
NCT01425060, a Phase 1 study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 31 participants
- Enrollment target
Study Summary
Nearly 9 of every 10 pregnant opioid-dependent women report that the current pregnancy was unintended and the majority of non-pregnant opioid-maintained women do not use contraception or use less effective methods like condoms. This proposal aims to develop and test a novel contraceptive management program to increase use of more effective contraceptives among opioid-maintained women and to examine the impact of more effective contraceptive use on condom use. The proposed research may reduce unintended pregnancy among opioid-dependent women without increasing their risk of sexually transmitted infections and the knowledge gained will also have implications for addressing high rates of unintended pregnancy in the general population.
Interventions
- OTHER Usual care
- BEHAVIORAL Contraceptive management program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2011-10 |
| Est. Completion | 2014-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01425060
The ClinicalTrials.gov registry entry for NCT01425060 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.
NCT01425060 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01425060 about?
NCT01425060 is a clinical study titled "Improving Effective Contraceptive Use Among Opioid-maintained Women". Nearly 9 of every 10 pregnant opioid-dependent women report that the current pregnancy was unintended and the majority of non-pregnant opioid-maintained women do not use contraception or use less effective methods like condoms. This proposal aims to develop and test a novel contraceptive management ...
What is the current status of trial NCT01425060?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 31 participants. The study started on 2011-10. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01425060?
The interventions under investigation include: Usual care (OTHER), Contraceptive management program (BEHAVIORAL).
Who is sponsoring clinical trial NCT01425060?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.